Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Orally active ET antagonist from BMS in clinical trials

July 18, 1997

Nippon Shinyaku reveals new series of carboxylic acid derivatives

July 18, 1997

Yamanouchi discloses Na+/H+-exchange inhibitors for cardiovascular indications

July 18, 1997

Agents for increasing HDL cholesterol from American Home Products

July 18, 1997

Zambon develops dual ACE/NEP inhibitors

July 18, 1997

New cardiovascular drugs reported by Yamanouchi

July 17, 1997

Kanebo reports novel cell adhesion inhibitors

July 17, 1997

Dual mechanism of action for antiatherosclerotic compound Org-13061

July 16, 1997

Eclipse submits PMA for Transmyocardial Revascularization procedure

July 15, 1997

Potent and selective M2 receptor antagonist discovered by Yamanouchi

July 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...